CYTENA BPS Revenue and Competitors
Estimated Revenue & Valuation
- CYTENA BPS's estimated annual revenue is currently $3.4M per year.
- CYTENA BPS's estimated revenue per employee is $155,000
Employee Data
- CYTENA BPS has 22 Employees.
- CYTENA BPS grew their employee count by -21% last year.
CYTENA BPS's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Finance & Legal Positions | Reveal Email/Phone |
CYTENA BPS Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is CYTENA BPS?
cytena Biorprocess Solutions provide high through put microbioreactor in the early cell line development, our first product - c.bird™ is a high throughput microbioreactor for parallel cultivations in 96/24 well plates, bringing production bioreactors environments into 150-1600 µI microbioreactor scale. It enables earlier identification of the highest producing and most stable clones, reduces later passaging steps and efforts of current scaling-up process.
keywords:N/A
N/A
Total Funding
22
Number of Employees
$3.4M
Revenue (est)
-21%
Employee Growth %
N/A
Valuation
N/A
Accelerator
CYTENA BPS News
2022-04-17 - The BICO Group has been awarded 7 iF design awards for excellence in
product design
BICO Biosciences was awarded an impressive 4 awards in total (Discover Echo 2, Cytena BPS 2), 2 awards were awarded to companies in BICO...
Other Companies in Taipei
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.4M | 22 | 22% | $20M |
#2 | $3.4M | 22 | 5% | N/A |
#3 | $2.2M | 24 | -8% | N/A |
#4 | $3.6M | 25 | 0% | N/A |
#5 | $3.7M | 25 | -14% | N/A |